Sugi Holdings Co.,Ltd. (TYO:7649)
3,750.00
+104.00 (2.85%)
Nov 21, 2025, 3:30 PM JST
Sugi Holdings Revenue
Sugi Holdings had revenue of 254.71B JPY in the quarter ending August 31, 2025, with 19.67% growth. This brings the company's revenue in the last twelve months to 964.38B, up 21.81% year-over-year. In the fiscal year ending February 28, 2025, Sugi Holdings had annual revenue of 878.02B with 17.94% growth.
Revenue (ttm)
964.38B
Revenue Growth
+21.81%
P/S Ratio
0.70
Revenue / Employee
81.59M
Employees
11,820
Market Cap
678.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 878.02B | 133.54B | 17.94% |
| Feb 29, 2024 | 744.48B | 76.83B | 11.51% |
| Feb 28, 2023 | 667.65B | 42.17B | 6.74% |
| Feb 28, 2022 | 625.48B | 22.97B | 3.81% |
| Feb 28, 2021 | 602.51B | 60.55B | 11.17% |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |